• Dry Cracked Skin
  • General Dermatology
  • Impetigo
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

Dermala is Granted Patent for Microbiome Anti-Aging


Dermala announces a patent for compositions and methods for preventing, slowing, and reversing skin aging.

Dermala, a consumer dermatology company who develops novel, personalized, microbiome-based treatments for multiple skin conditions, has announced the issuance of the U.S. Patent No. 11,103,443 - compositions and methods for preventing, slowing, and reversing skin aging.1

The patent covers using the human microbiome to slow down the skin aging process, according to the press release. Typical signs of skin aging are wrinkles, loss of skin elasticity, skin sagging, blemishes, and hyperpigmentation. As a person ages, the microbiomes of the skin and gut change as well. The goal of Dermala’s patented technology is to balance the microbiome and restore younger skin and gut microbiomes in older adults. 

Dermala transplants “younger” skin and gut microbiomes or their biosynthetic equivalents— prebiotics, probiotics, and postbiotics—to older skin. The company says this results in a rebalanced microbiome, the reduction of fine lines and wrinkles, improved skin hydration, increased ceramide and collagen production, reduced inflammation, improved skin barrier function and elasticity, and a younger complexion.

"Skin aging is associated with changes in skin and gut microbial communities," says Lada Rasochova, PhD, MBA, founder and CEO of Dermala and patent inventor, San Diego, California. "Differences between younger and older microbiomes can be striking. Optimizing the microbiome composition by transplanting biologically younger microbiome components onto an aging skin to slow down aging is a novel concept that is poised to revolutionize the skincare industry."

This patent expands Dermala's intellectual property portfolio, which includes using the skin and gut microbiomes and data analytics to treat skin diseases and conditions such as acne, eczema, and skin aging.


1. Dermala, a consumer dermatology company, announces issuance of a new U.S. Patent covering the use of human microbiome to prevent, slow, and reverse skin aging. Cision PR Newswire. Press release. Published September 13, 2021. Accessed September 16, 2021. https://www.prnewswire.com/news-releases/dermala-a-consumer-dermatology-company-announces-issuance-of-a-new-us-patent-covering-the-use-of-human-microbiome-to-prevent-slow-and-reverse-skin-aging-301374929.html

Related Videos
© 2024 MJH Life Sciences

All rights reserved.